Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

CUSIP: 03168L105

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 7 signals
Share change
+7,722,099
Put/Call ratio
0%
SEC-reported price per share
$10.01
Number of holders
243
Value change
+$80,688,644
Number of buys
130
Open additional details 1 more signal available
Number of sells
103
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
348,532,261

Security key

03168L105

Report period

Q3 2025

Institutions

243

Top holders

10

Ownership snapshot

Top reported holders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Akram Mahesh
Disclosed value leader
Akram Mahesh
Comparable rows
2/15
Latest evidence
30 Jun 2025
13D/G 13F 3/4/5 Lead comparable stake: 6.6% 13 rows are not safely comparable across share classes. 13D/G row: Akram Mahesh Showing 1-6 of 15 holder rows.

Quick read

Akram Mahesh leads the comparable SEC ownership view at 6.6%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Akram Mahesh's linked filing trail.
Comparable ownership Top 2
Akram Mahesh 6.6%
VANGUARD GROUP INC 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Akram Mahesh
13D/G
6.6%
Reported 13D/G · 31 Mar 2025
$153,779,517
20,558,759 shares
$0 31 Mar 2025
VANGUARD GROUP INC
13F 13D/G
Company · The Vanguard Group
5%
Reported 13D/G · 31 Mar 2025
$141,990,753
17,551,391 shares
— 30 Jun 2025
TPG GP A, LLC
13F 3/4/5
Company · Former 10% Owner
—
denominator unverified
$99,739,725
12,328,767 shares
— 30 Jun 2025
Dipan Patel
3/4/5
Member of 13D Group
—
denominator unverified
$111,029,165
26,905,073 shares
— 07 Nov 2023
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$98,142,697
12,131,359 shares
— 30 Jun 2025
Rubric Capital Management LP
13F
Company
13F
—
denominator unverified
$94,736,586
11,710,332 shares
— 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
243
Shares
150,638,837
Rows available
243
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
237
Q3 2025 holders
243
Holder diff
6
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .